Oorsprong van het eerstegraads netwerk van Robert Schiestl
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
RESprotect GmbH
 RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany.
9
| Holding Company | Pharmaceuticals: Other | 9 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Robert Schiestl via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| PROPANC BIOPHARMA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Bonn | College/University | Corporate Officer/Principal | |
UroTiss GmbH
 UroTiss GmbH Medical/Nursing ServicesHealth Services UroTiss Gmbh researches, develops, and manufactures pharmaceuticals for the treatment of urethral strictures and hypospadias. The company was founded by Dr. Gouya Ram-Liebig in 2005 and is headquartered in Dortmund, Germany. | Medical/Nursing Services | Director of Finance/CFO |
Statistieken
Internationaal
| Duitsland | 3 |
| Australië | 2 |
Sectoraal
| Health Technology | 2 |
| Consumer Services | 2 |
| Health Services | 2 |
Operationeel
| Corporate Officer/Principal | 5 |
| Chief Tech/Sci/R&D Officer | 3 |
| Director of Finance/CFO | 2 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sterkste connecties
- Beurs
- Insiders
- Robert Schiestl
- Bedrijfsconnecties
